Kenneth Palmer
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Safety, Tolerability, and Pharmacokinetics of Q-Griffithsin Intranasal Spray (NCT05437029) | Kenneth Palmer | 2022-06-15 |
| PREVENT-COVID-19: A Q-Griffithsin Intranasal Spray (NCT05122260) | Kenneth Palmer | 2021-11-11 |
Track Kenneth Palmer automatically
Every clearance here is in the API, with alerts when new ones post.